Results 141 to 150 of about 4,320,983 (278)

Cost-effectiveness of interferon in chronic myeloid leukaemia: Analysis of four clinical studies

, 1998
Andrea Messori
openalex   +1 more source

Salmeterol xinafoate: an analysis of outcomes and cost-effectiveness using a primary care database

, 1998
David Price, K. Cargill, Stephanie Wolfe, H. Darby   +3 more
openalex   +1 more source

Strategies for Prevention of Varicella Pneumonia: A Cost‐Effectiveness Analysis [PDF]

, 1996
George A. Macones, Stephanie Ewing, Neil S. Silverman   +2 more
openalex   +1 more source

Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis

ClinicoEconomics and Outcomes Research, 2019
Alberto Migliore,1 Davide Integlia,2 Giuseppe Pompilio,2 Francesca Di Giuseppe,2 Cinzia Aru,2 Tray Brown31Unit of Rheumatology, San Pietro Fatebenefratelli Hospital, Rome, Italy; 2ISHEO Srl, Rome, Italy; 3Department of Public Health and Primary Care ...
Migliore A, Integlia D, Pompilio G, Di Giuseppe F, Aru C, Brown T   +5 more
doaj  

PIC5 Cost-Effectiveness Analysis of Piperacillin-Tazobactam Versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections

, 1998
A. Domínguez‐Gil, Cristina Díaz de Heredia   +1 more
openalex   +1 more source

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

ClinicoEconomics and Outcomes Research, 2012
Alain Vergnenègre1, Joshua A Ray2, Christos Chouaid3, Francesco Grossi4, Helge G Bischoff5, David F Heigener6, Stefan Walzer21Department of Pneumology, Hôpital du Cluzeau, Limoges, France; 2Global Health Economics and Strategic ...
Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S   +6 more
doaj  

Does Cost-Effectiveness Analysis Discriminate against Patients with Short Life Expectancy? [PDF]

Does the use of quality-adjusted life-years (QALYs) in cost-effectiveness analyses (CEAs) of health care interventions necessarily discriminate against patients with short life expectancy compared with others?
Anthony J. Culyer, Mike Paulden
core  

Cost-Effectiveness Analysis of Pitavastatin in Dyslipidemia: Vietnam Case. [PDF]

Healthcare (Basel)
Vo NX, Nguyen HTM, Phan NM, Pham HL, Bui TT, Bui TT.   +5 more
europepmc   +1 more source

Low doses vs. high doses of the angiotensin converting‐enzyme inhibitor lisinopril in chronic heart failure: a cost‐effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study [PDF]

, 2000
Mark Sculpher, Lynne Poole, John G.F. Cleland, Michael Drummond, Paul W. Armstrong, John D. Horowitz, Barry M. Massie, Philip A. Poole‐Wilson, Lars Rydén   +8 more
openalex   +1 more source

Cost-Effectiveness Analysis of First-Line Chemotherapy for Metastatic Pancreatic Cancer in Japan. [PDF]

Cancer Med
Sasahara Y, Takumoto Y, Murata T, Akazawa M, Narimatsu H.   +4 more
europepmc   +1 more source